These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2454950)

  • 21. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
    Podack ER; Preissner KT; Müller-Eberhard HJ
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A monoclonal antibody to alcohol dehydrogenase cross-reacts with human complement component C3.
    Leone NA; Whitehouse DB; Swallow DM; Adinolfi A
    Exp Clin Immunogenet; 1993; 10(1):50-5. PubMed ID: 7691112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural analysis of sulphated glycoprotein 2 from amino acid sequence. Relationship to clusterin and serum protein 40,40.
    Tsuruta JK; Wong K; Fritz IB; Griswold MD
    Biochem J; 1990 Jun; 268(3):571-8. PubMed ID: 2363694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.
    Niculescu F; Hugo F; Rus HG; Vlaicu R; Bhakdi S
    Clin Exp Immunol; 1987 Aug; 69(2):477-83. PubMed ID: 3652536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glomerular complement components in human glomerulonephritis.
    Verroust PJ; Wilson CB; Cooper NR; Edgington TS; Dixon FJ
    J Clin Invest; 1974 Jan; 53(1):77-84. PubMed ID: 4586873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
    Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
    Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and characterization of bovine complement component C3 and its cleavage products.
    Di Carlo AL; Paape MJ; Hellman J; Lilius EM
    Am J Vet Res; 1997 Jun; 58(6):585-9. PubMed ID: 9185962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of vitronectin (S-protein of complement) in normal human skin.
    Dahlbäck K; Löfberg H; Dahlbäck B
    Acta Derm Venereol; 1986; 66(6):461-7. PubMed ID: 2433863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clusterin enhances the formation of insoluble immune complexes.
    Wilson MR; Roeth PJ; Easterbrook-Smith SB
    Biochem Biophys Res Commun; 1991 Jun; 177(3):985-90. PubMed ID: 2059225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent complement activation on tumor cells in breast cancer.
    Niculescu F; Rus HG; Retegan M; Vlaicu R
    Am J Pathol; 1992 May; 140(5):1039-43. PubMed ID: 1374587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40,40, an inhibitor of complement-mediated cytolysis.
    James RW; Hochstrasser AC; Borghini I; Martin B; Pometta D; Hochstrasser D
    Arterioscler Thromb; 1991; 11(3):645-52. PubMed ID: 1903064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C1q is a nucleotide binding protein and is responsible for the ability of clusterin preparations to promote immune complex formation.
    Roeth PJ; Easterbrook-Smith SB
    Biochim Biophys Acta; 1996 Oct; 1297(2):159-66. PubMed ID: 8917617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma.
    Mollnes TE; Lea T; Harboe M; Tschopp J
    Scand J Immunol; 1985 Aug; 22(2):183-95. PubMed ID: 4035298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SP-40,40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridges.
    Kirszbaum L; Bozas SE; Walker ID
    FEBS Lett; 1992 Feb; 297(1-2):70-6. PubMed ID: 1551440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The protein components of the acid-soluble fraction of normal human blood plasma and in peritonitis patients].
    Semenov VN; Azizov IuM; Makarshev IM; Nikolaevskikh SS; Iastrebova NE
    Anesteziol Reanimatol; 1992; (4):36-9. PubMed ID: 1485672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue.
    Falk RJ; Podack E; Dalmasso AP; Jennette JC
    Am J Pathol; 1987 Apr; 127(1):182-90. PubMed ID: 2952015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistological detection of C5b-9 complement complexes in normal and pathological human livers.
    Polihronis M; Machet D; Saunders J; O'Bryan M; McRae J; Murphy B
    Pathology; 1993 Jan; 25(1):20-3. PubMed ID: 7686292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes.
    Choi NH; Mazda T; Tomita M
    Mol Immunol; 1989 Sep; 26(9):835-40. PubMed ID: 2601725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sandwich ELISA assay for quantitative measurement of SP-40,40 in seminal plasma and serum.
    Choi NH; Tobe T; Hara K; Yoshida H; Tomita M
    J Immunol Methods; 1990 Aug; 131(2):159-63. PubMed ID: 2391426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.